Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Patrono

Showing results (11-20 of 257) with videos related to

Pageof 26
Sort By:
Nature Reviews. Cardiology|April 9, 2009
The P2Y12 receptor: no active metabolite, no partyCarlo Patrono
European Heart Journal|June 18, 2013
Low-dose aspirin in primary prevention: cardioprotection, chemoprevention, both, or neither?Carlo Patrono
Revista Espanola De Cardiologia (English Ed.)|April 30, 2014
Aspirin continues to attract research and debate, 115 years after its synthesisCarlo Patrono
European Heart Journal|August 8, 2022
Aspirin: 1A @ 125Carlo Patrono
Nature Reviews. Cardiology|August 1, 2012
Diabetes: Does aspirin increase the risk of major bleeds?Carlo Patrono
Journal of Cardiovascular Pharmacology|June 21, 2006
The PGH-synthase system and isozyme-selective inhibitionCarlo Patrono
European Heart Journal|December 14, 2020
The EHJ Weekly Journal Scan: Why? Who? How?Carlo Patrono
Current Cardiology Reports|February 5, 2016
Cardiovascular Effects of Nonsteroidal Anti-inflammatory DrugsCarlo Patrono
Cardiovascular Research|November 30, 2017
Fighting residual cardiovascular risk in stable patients with atherosclerotic vascular disease: COMPASS in contextCarlo Patrono
European Heart Journal|October 3, 2024
Weekly Journal Scan: Risk factors for recurrent ischaemic stroke in patients with atrial fibrillation on oral anticoagulationLeonarda Galiuto, Carlo Patrono
Pageof 26

Showing results (11-20 of 257) with videos related to

Sort By:
Pageof 26
Nature Reviews. Cardiology|April 9, 2009
The P2Y12 receptor: no active metabolite, no partyCarlo Patrono
European Heart Journal|June 18, 2013
Low-dose aspirin in primary prevention: cardioprotection, chemoprevention, both, or neither?Carlo Patrono
Revista Espanola De Cardiologia (English Ed.)|April 30, 2014
Aspirin continues to attract research and debate, 115 years after its synthesisCarlo Patrono
European Heart Journal|August 8, 2022
Aspirin: 1A @ 125Carlo Patrono
Nature Reviews. Cardiology|August 1, 2012
Diabetes: Does aspirin increase the risk of major bleeds?Carlo Patrono
Journal of Cardiovascular Pharmacology|June 21, 2006
The PGH-synthase system and isozyme-selective inhibitionCarlo Patrono
European Heart Journal|December 14, 2020
The EHJ Weekly Journal Scan: Why? Who? How?Carlo Patrono
Current Cardiology Reports|February 5, 2016
Cardiovascular Effects of Nonsteroidal Anti-inflammatory DrugsCarlo Patrono
Cardiovascular Research|November 30, 2017
Fighting residual cardiovascular risk in stable patients with atherosclerotic vascular disease: COMPASS in contextCarlo Patrono
European Heart Journal|October 3, 2024
Weekly Journal Scan: Risk factors for recurrent ischaemic stroke in patients with atrial fibrillation on oral anticoagulationLeonarda Galiuto, Carlo Patrono
Pageof 26